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Abstract
Background: In developing countries, the private sector provides a substantial proportion of primary health care to low
income groups for communicable and non-communicable diseases. These providers are therefore central to improving
health outcomes. We need to know how their services compare to those of the public sector to inform policy options.
Methods and Findings: We summarised reliable research comparing the quality of formal private versus public ambulatory
health care in low and middle income countries. We selected studies against inclusion criteria following a comprehensive
search, yielding 80 studies. We compared quality under standard categories, converted values to a linear 100% scale,
calculated differences between providers within studies, and summarised median values of the differences across studies.
As the results for for-profit and not-for-profit providers were similar, we combined them. Overall, median values indicated
that many services, irrespective of whether public or private, scored low on infrastructure, clinical competence, and practice.
Overall, the private sector performed better in relation to drug supply, responsiveness, and effort. No difference between
provider groups was detected for patient satisfaction or competence. Synthesis of qualitative components indicates the
private sector is more client centred.
Conclusions: Although data are limited, quality in both provider groups seems poor, with the private sector performing
better in drug availability and aspects of delivery of care, including responsiveness and effort, and possibly being more
client orientated. Strategies seeking to influence quality in both groups are needed to improve care delivery and outcomes
for the poor, including managing the increasing burden of non-communicable diseases.
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Introduction
The private sector is the main provider of primary health care
for the poor in many low and middle income countries (LMICs).
For example, in South Asia about three quarters of children from
the poorest income quintile with acute respiratory conditions
seeking health care go to a private provider [1], and about 45% of
sick children from the poorest income quintile across 26 African
countries go to a formal or informal private provider rather than a
public provider for health care [2]. Private providers are also
increasingly important for providing ambulatory care as non-
communicable diseases (NCDs) increase [3].
Private providers may be ‘‘formal’’, i.e. recognised by law or by
legally recognised regulatory authorities, or ‘‘informal’’, i.e. not
recognised [4]. Formal private providers include ‘‘for-profit’’
hospitals and self-employed practitioners, and ‘‘not-for-profit’’
non-governmental organizations (NGOs). NGOs include church-
es, and are particularly common in Africa, although the for-profit/
not-for-profit dichotomy is not so clear cut in practice, with some
NGOs simply representing private practitioners securing tax
breaks [5,6]. Informal allopathic providers include ‘‘quacks’’, lay
health workers, drug sellers, and ordinary shop keepers [7].
Advocating that formal for-profit private services are preferable to
government provision raises considerable ideological debates [8–10];
equally, not-for-profit private providers such as those run by
churches are seen by some as good and as providing value for
money [11]. Whatever the debates, there is agreement that
influencing the quality of both public and private providers could
have a major impact on health outcomes. Adequate state
stewardship and oversight of these mixed systems is widely advocated
[9,12], but the mechanisms to assure quality are not simple and are
of unclear effectiveness [13,14]. Improving stewardship and
oversight is complex, involving resources, management, legislation,
and approaches to influence the market [15,16]. Thus, an
understanding of how quality and performance in the formal private
sector compares with that of the public sector would help
governments to focus strategies to improve delivery. Putting this
simply, if the private sector is generally providing poorer quality care
than the public sector, then there is an imperative to improve the
quality and outcomes; on the other hand, if the quality of private-
sector care is good, the priority for policy is to influence the market
somehow to further improve access for low income groups.
‘‘Quality’’ has many dimensions [17], including structural
quality, aspects of delivery, and the technical or professional
content of care, all of which are likely to influence service use.
Each dimension will have complex effects on patient satisfaction,
patient use of the service, and outcomes for their health. In
addition, each is interrelated: population health outcomes will
depend on service use, technical quality, and drug availability, for
example. A recent substantive analysis that examined the use of
medicines in primary care reported poor quality prescribing for
both sectors, with little change over time [18]. The authors also
reported the relatively poor quality of data and the need for
research assessing the difference between the public and private
sector. Thus, our objective was to systematically identify and
summarise the results of studies that directly compare the quality
of private providers and public services in relation to ambulatory
health care in LMICs.
Methods
Criteria for Inclusion
We included field-based studies that directly compared service
quality in ambulatory care from private versus public medical
health services. The purpose was to include studies using the same
methods to measure the differences, and in the same countries, to
avoid confounding factors related to overall differences in service
quality between countries. We included studies conducted in
LMICs that assessed ambulatory care, defined as the ‘‘delivery of
personal health care services on an outpatient basis’’ [19]. We only
included studies that compared private and public services in the
same country, at the same time, using the same methods, and
which met particular quality criteria (Table S1). ‘‘Private’’ refers to
‘‘all organizations and individuals working outside the direct
control of the state’’ [20], and we included only those working
within the allopathic medical systems. ‘‘Private for-profit provid-
ers’’ included individuals or groups of practitioners in privately
owned clinics, hospitals, and pharmacies that operate on a for-
profit basis, while ‘‘private not-for-profit providers’’ included
practitioners in facilities that operate on a non-profit basis, such as
various (missionary or non-missionary) NGOs and private
voluntary organizations. Informal providers included those
without formal health professional qualifications, such as street
vendors and shop keepers. We included studies reported in
English, French, or German and published from January 1970 to
April 2009. We screened all titles/abstracts found by the search
methods described below for potential inclusion, and then
carefully applied the detailed inclusion criteria (Table S1) to the
full text of those identified in the screening search. Studies using
qualitative methods were identified and were included if they (a)
used internationally accepted data collection methods (e.g., in-
depth interviews, focus group discussion, or observation), (b)
indicated the methods used in analysis (e.g., thematic analysis,
content analysis, or grounded theory), and (c) presented data by
theme or in the form of verbatim quotes.
Search Methods
The search strategy for Medline can be found in Table S2, and
a list of the databases searched in Table S3. In addition, we
searched all records of the World Health Organization’s (WHO’s)
library database, WHOLIS (on 27 April 2009), all Service
Availability Mapping reports published on the WHO Web site
(http://www.who.int/healthinfo/systems/samdocs/en/index.html)
(on 5 December 2010) [21], all Service Provision Assessment Survey
reports published on the Measure DHS Web site (http://www.
measuredhs.com/aboutsurveys/search/search_survey_main.cfm?
SrvyTp= type&listtypes = 3) (on 3 December 2010) [22], and all
research studies published on the Core group Web site (http://
www.coregroup.org/) (on 6 December 2010), and we examined
reference lists of relevant reviews [23–25] and of the included
studies.
The search strategies included indexed and free-text terms:
health sector, health care, delivery of health care, primary health
care, medical care, health clinic, outpatient service, ambulatory
care, practitioner, health provider, health provision, hospital,
pharmacy, drug vendor, drug seller, drug store, public sector,
public, private sector, private, quality of health care, Africa, Asia,
South America, developing countries, less developed countries,
third world countries, underdeveloped country, low income
country, low income nation, middle income country, middle
income nation, low and middle income countries.
Data Collection and Analysis
We applied the inclusion criteria to all titles and abstracts. We
retrieved full-text copies of potentially relevant records, and
discussed each to resolve uncertainties. We then appraised
potential studies against a set of basic minimum methodological
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criteria to exclude studies where data were unlikely to be reliable
(Table S1).
We adapted Donabedian’s [17] classification of quality of care
using structural, delivery, and technical categories (Table 1). We
incorporated ‘‘responsiveness’’ [26] to reflect aspects such as
waiting time, communication quality, and dignity, as well as an
assessment of the ‘‘effort’’ providers make, such as whether they
examine the patient, and the length of the consultation time
[27,28], and we divided technical quality into measures of
competence and clinical practice (Table 1).
S. B. extracted data using a standard form, entered into an
Access database, with about 80% verified by a second author to
ensure standardisation of coding. We contacted 33 authors for
further information, and all but nine authors responded. Standard
data describing the study were extracted. If a study reported
several comparisons, we selected groups that were most similar
within the health system (e.g., public hospitals versus private
hospitals, or public health centres versus private clinics). If results
were presented separately for different cadres or levels of staff
qualification, we chose the comparison group with the staff
qualification levels that were most comparable and most
frequented by the population. If the latter could not be established,
we chose the highest qualified comparison group.
We then separately computed summary measures of (a) the
overall level of quality of care in the private and in the public
sector and (b) the difference of quality of care between both sectors
stratified by quality categories and components. If there were
several data measures for one component in a study, we computed
the median for all reported measures to calculate a single measure
for component quality for the provider. For example, in the case of
a public-sector score (on a linear scale, with 100% being the
maximum obtainable) of 45% for physical infrastructure, 50% for
availability of basic diagnostic equipment, and 60% for availability
of basic material, the median for the structural component
‘‘building, equipment, and material’’ would be 50%. The median
was also computed for the quality score difference between private
and public provider. For example, in case of a difference of +5% in
physical infrastructure, +11% in availability of basic diagnostic
equipment, and +14% in basic material, the median difference
would be +11% for the given comparison in a study. After
computing the medians for the overall quality of care and for the
difference of care for each single comparison in each study, we
computed medians and inter-quartile ranges (IQRs) across all
comparisons. The size of the difference and the IQRs of the
difference were used to judge whether a difference was evident.
Results
Of 8,812 titles and abstracts identified, 80 studies included direct
quantitative comparisons of public and private formal providers
(Figure 1, adapted from PRISMA 2009 flow diagram [29]; Tables S4
and S5 describe excluded studies). These yielded 133 comparisons, of
which we were able to convert 101 to a 100% scale (Table S6). Most
studies were carried out after 1990; they were mainly conducted in
sub-Saharan Africa (n= 39) and in Asia and the Pacific (n= 23); and
most were intended to compare quality, examining all types of
primary service and disease category (Table 2; details in Table S9).
Most studies did not report socio-economic status of public and
private service users, and only five presented data by different wealth
groups [30–34]. No study compared the same individual providers
working in public and private care settings. For two studies [35,36]
that reported results separately for different cadres, we chose public
versus private doctors rather than public versus private nurses or
midwives as comparison groups, but it should be noted that for both
groups results pointed in the same direction.
We found only two studies comparing public providers and
private informal providers. The first [37] compared malaria-
related knowledge and chloroquine availability in public dispen-
saries and informal drug vendors, and suggested that the public
sector was slightly better. The second [38] mixed both formal and
informal private providers together. These two studies were
excluded from further analysis.
Of the 101 formal private versus public sector comparisons that
were converted to a 100% scale, 57 compared government with
private for-profit providers, 10 with a mix of for-profit and not-for-
profit providers, and 34 with private not-for-profit providers. Of the last
34 comparisons, most (n=29) were conducted in sub-Saharan Africa.
Study-level summary values for each quality component are
presented in Table 3, along with the summary of the within-study
differences. We also carried out an analysis that separated private
for-profit and private not-for-profit providers (Table S7). As the
results in the for-profit and not-for-profit providers were
remarkably consistent, they are presented as combined.
In addition, ten studies included qualitative data that met our
eligibility criteria, with a similar geographic spread to the
quantitative data.
Structure
For buildings, equipment, materials, and supplies, no difference
was detected. For the 26 comparisons, the IQR of the difference
included 0. Respondents in two qualitative studies reporting on
this category described private facilities as better [39,40].
Table 1. Quality categories, sub-categories, and indicators used.
Quality Category Sub-Category Description and Indicators
Structural Building, equipment, materials Availability and condition of health facilities, and of defined equipment,
materials, and supplies
Drug availability Availability of essential drugs in health facilities and pharmacies
Delivery Responsiveness Waiting time, privacy, confidentiality, staff friendliness, communication, dignity
Effort Length of consultation time, whether a physical examination is performed,
number of explanations given
Patient satisfaction Patients’ satisfaction with last consultation
Technical Competence Professional knowledge and skills
Clinical practice Presence or absence of critical elements of care, whether practice is according
to standards or guidelines, proxies for correct prescribing behaviour
doi:10.1371/journal.pmed.1000433.t001
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For drug availability, private-sector care was substantially better
than public-sector care, from 14 comparisons. Nine studies used a
standard method and referred to the WHO essential drug list
[41,42]. None of the quantitative studies compared the quality of
drugs available in the public versus private sector. Qualitative
studies reported that the private sector was more trusted for drug
Figure 1. Selection of studies. * See Table S4 for reasons of exclusion; { see Table S5 for reasons of exclusion.
doi:10.1371/journal.pmed.1000433.g001
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quality [43] and that the drugs were more readily available
[39,40,44,45].
Service Delivery
For responsiveness, private-sector care was better (see Table 1
for definition), from seven comparisons. Studies used patient
interviews, observations, or simulated visits. In six of the seven
comparisons measuring waiting time, the time was shorter in the
private sector. Qualitative data in five studies indicated that the
private sector provided more personalised, respectful [39,
40,46,47], listening [43], and client-centred service, as well as
service that was more convenient [48] and quicker and easier to
access [47,49].
For effort, private-sector care was better, from three compar-
isons. A further four studies reported on average consultation
times, which were longer in the private sector in all studies,
although statistical significance was only computed and confirmed
in two of them [6,50–52]. Qualitative data were consistent with
this finding. Studies consistently reported criticisms of the public
sector (with providers showing favouritism for some patients and
less respect for poorer clients [39,40,43,44,46,48,49]) and praise
for the private sector [39,40,43,48,49].
For patient satisfaction, no difference between private and
public sector was detected, from ten comparisons. None of the
studies measuring ‘‘satisfaction’’ reported the use of a validated
questionnaire. Only one took into account possible differences in
expectations of public and private services [53].
Technical Quality
For competence, scores for private- versus public-sector care
were similar, and generally poor, from 19 comparisons; compe-
tence was measured by case scenarios or vignettes, provider
interviews, or a formal test. In qualitative studies the private sector
was reported as quicker and easier to access, although the
competence of some providers was questioned [40,48]. The public
sector was often perceived as technically competent but inconve-
Table 2. Characteristics of quantitative studies comparing public and formal private providers by region (n = 80).
Characteristic
South Asia,
East Asia, and Pacific
Sub-Saharan
Africa Othera
Total Number of
Studies
Language
English 23 33 16 72
French 0 6 2 8
Study year range
1980–1989 1 2 1 4
1990–1999 8 16 7 31
2000–2009 14 21 10 45
Primary study purpose
Describe or compare quality of private and public services 17 28 13 58
Assess drug availability and affordability 4 3 2 9
Assess demand for, access to, or utilisation of services, or
efficiency of service delivery
2 8 3 13
Service type
Promotive or preventive 1 4 2 7
Curative, rehabilitative, or palliative 7 14 7 28
All types 12 18 8 38
Not specified 3 3 1 7
Disease category
Both CD and NCD 14 24 9 47
CD 7 13 5 25
NCD 1 0 3 4
Not specified 1 2 1 4
Population age
Adult 6 11 2 19
Both adult and child 15 21 7 43
Child 1 3 4 8
Not specified 1 5 5 11
Population gender
Both (male and female) 21 34 15 70
Female 2 5 3 10
Total number of studies 23 39 18 80
aIncludes Europe and Central Asia (n= 1), Latin America and the Caribbean (n= 6), the Middle East and North Africa (n= 7), and studies reporting on countries in more
than one world region (n= 4).
doi:10.1371/journal.pmed.1000433.t002
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nient and provider centred, with complex systems that took time
and effort to negotiate [44,47,49,54].
For clinical practice, private-sector care was marginally
better, from 22 comparisons. Of those not convertible to a
linear 100% scale, 14 studies used the same standard methods to
assess prescribing behaviour, summarised in Table S8, with no
obvious differences. In qualitative studies, respondents per-
ceived public providers as qualified and well trained [43],
although some were thought to overprescribe to raise their
income [40,48]. The private sector was also criticised for
overprescribing and collusion between doctors and pharmacists
[46], for suspected ‘‘fake’’ or unlabelled drugs, for ‘‘fake’’
doctors, and for nurses practicing illegally in private pharmacies
in need of regulation [40,46,48].
We carried out a sensitivity analysis including only studies and
comparisons (n = 67) classified as high quality because of their size
(Table S1 provides the criteria); the results obtained were very
similar to Table 3.
For-Profit and Not-for-Profit Providers
As mentioned above, most of the not-for-profit studies were
carried out in sub-Saharan Africa (29 of 34 comparisons). Table
S7 contains an analysis stratified by private for-profit and private
not-for-profit. The direction of the difference is the same as for the
aggregated value for all components. Notably, clinical practice was
much better in the for-profit sector, and the difference was less
marked for the not-for-profit sector, but the number of
comparisons in the for-profit sector is limited.
Factors Contributing to a Quality Difference
Some of the qualitative studies (n = 8) sought to explain the
quality difference between the two sectors. Factors perceived to be
related to low public-sector quality included resource constraints,
low salaries, high workload, and poor incentives and conditions of
service [39,40,44], the lack of a public family/general practice
system that enables patients to return to the doctor(s) of their
choice and develop relationships of trust over longer periods of
time [43], public-sector drugs being sold privately [39,40], staff
favouring particular patients [39,47], and clients lacking sufficient
information about the appropriate use of drugs, resistance to
antibiotics, costs, and their rights to challenge poor service
[39,46,49,54].
Discussion
Summary
The results of our analyses indicate that, in both private and
public sectors, median values for structure, competence, and
clinical practice fall around or below scores of 50/100. Whilst
these values depend on the instruments used and the stringency of
the primary research studies in applying these standards, the
trends provide some insight into absolute performance, with
obvious problems with technical aspects of care in both sectors.
In comparative performance, the formal private sector was
better for drug availability, responsiveness, and effort. Overall, the
median differences were modest, so stereotyped opinions that one
sector is clearly better than another are not supported by this
review.
Qualitative data portrayed formal private services that, in
contrast to the public sector, were more client centred. This is
consistent with the differences in care delivery shown by the
quantitative data.
Interpretation
In a formal private setting, drugs may be more available
because funds are not restricted in the same way as in the public
sector, and private providers are motivated to encourage patients
to return, so responsiveness and effort are greater.
These results, combined with the fact that the private sector
provides a substantial amount of health services, raise two further
issues—the importance of paying attention to both sectors if
overall quality is to be raised, and the need for governments to
play a more active role in assuring quality of care.
Many efforts to improve the quality of ambulatory care are
restricted to the public sector on the grounds that public funds
should be reserved for the public sector because that is where the
poor turn for their health care. But concentrating on the public
sector misses a large proportion, the majority in some cases, of the
providers used by the poor. Raising the quality of care delivered by
private, as well as public, providers would, in fact, be a pro-poor
intervention as it would improve the effectiveness of the money the
poor spend on health care. A second argument advanced against
spending public money on private providers is that because they
provide a lower quality of care it is more effective to reserve funds
for the public sector. The results of this review indicate that the
Table 3. Overall level of quality and comparative quality difference of public and formal private providers.
Category Component
Number of
Comparisons
Converted to
100% Scale Public Quality Score (%) Private Quality Score (%) Difference Private-Publica (%)
Median IQR Median IQR Median IQR
Structural Building, equipment, and
materials
26 41.9 25.0, 76.5 44.5 22.0, 86.6 2.8 22.9, 20.6
Drug availability 14 45.3 38.8, 58.5 63.0 45.4, 94.8 17.9 12.5, 29.1
Delivery Responsiveness 7 85.0 56.9, 86.3 89.1 75.7, 94.5 7.5 7.0,12.4
Effort 3 84.9 46.5, 87.0 92.9 54.5, 93.5 8.0 5.5, 8.0
Patient satisfaction 10 75.0 56.9, 78.8 75.0 68.0, 79.1 0.5 22.0, 4.4
Technical Competence 19 52.8 36.3, 54.2 45.2 35.0, 53.3 23.0 27.6, 0.8
Clinical practice 22 44.5 27.5, 60.9 47.0 39.1, 66.5 5.2 1.3, 14.0
aWithin each comparison, the difference between the public score and the private score was calculated. The data in this column are the median of these values across
all studies. For this reason, they will not correspond to an arithmetic difference of the absolute median scores in the previous columns.
doi:10.1371/journal.pmed.1000433.t003
Quality of Private Versus Public Care
PLoS Medicine | www.plosmedicine.org 6 April 2011 | Volume 8 | Issue 4 | e1000433
overall quality of care from the two sets of providers is similar; if
anything, the private sector is more responsive and drug
availability is greater.
The overall low quality of care is likely to become even more so
as the double burden of communicable disease (CD) and NCD
becomes more prominent. Most health care providers, public or
private, practicing today have been trained by institutions and
work in health systems primarily oriented to CDs. Consequently,
providers have only limited knowledge of NCDs, which demand a
different set of clinical skills and a different approach to treatment.
On most dimensions, effective treatment for NCDs requires
approaches quite different to those that are available through the
current health systems, and, contrary to views held by many,
NCDs and associated risk factors are not the preserve of the rich;
they are equally, if not more, prevalent among the poor [55].
Thus, it has to be considered that certain types of diseases, such as
some NCDs, but also more complex CDs, such as AIDS, might
require particularly high levels of structural quality, drug
availability, and provider competence, while for other diseases,
such as childhood diarrhoea, that are easy to diagnose and treat, it
is most important to motivate providers to exert effort and practice
what they already know [56].
Raising the quality of care in a health system is a long-term
effort and requires attention to various aspects, including the
incentive structure and training, both areas in which government
has an important role, but to which it frequently pays little
attention. Systematic and comprehensive traditional narrative
reviews suggest a variety of strategies that can help increase
quality. For example, supervision and audit with feedback,
especially if combined with training, have been found to be
effective [57]. However, an overall government bias against the
private sector frequently means that too little attention is paid,
and too few resources devoted, to overall supervision of the
private sector. But setting standards, partly through ensuring
standards of training, partly through licensing and accreditation
of professionals (including emphasis on continuing education),
and partly through consumer protection laws, is an important
role of government [16,58]. Researchers such as Leonard and
colleagues [15] have provided useful theoretical frameworks for
influencing the private sector based on the ‘‘principal-agent
theory’’. Others have proposed different ways of classifying the
variety of strategies that have so far been used to improve the
quality of private care, for example, classifying strategies
according to the influence they have either on supply or demand
or on the overall market environment [16,59]. However,
empirical evidence on the effectiveness of various approaches is
somewhat limited, as the review by Peters et al. shows for
reproductive health care [14].
Strengths and Weaknesses of This Review
The search was comprehensive, the inclusion criteria were
applied carefully, and quality criteria were applied to ensure
comparisons were valid and were direct comparisons using the
same methods. Given that studies used a very varied set of tools to
measure quality of care, results on the absolute level of quality of
care have to be interpreted with caution. However, results on the
difference in quality of care can be interpreted with more
confidence, because, as mentioned above, we took care to include
only those studies that directly compared quality of care in the
same country at the same time, using the same methods. A further
strength is that we were able to categorise the various quality
components to allow comparisons between studies. A disadvantage
is that small studies could contribute as much to the estimates as
large studies, but the sensitivity analysis—excluding the smaller
studies—did not alter the direction of the differences between the
sectors.
Although this review fully assessed eligible comparative studies
on quality, additional work is needed to compare costs and aspects
of equity. Similar to the dispute on quality, there are controversial
views on whether private or public care is more costly or more
accessible to the poor.
The review also highlights the lack of comparative evidence
between the public sector and the private informal sector,
although the latter is widely used [2,60].
Implications for Policy and Research
With the current evidence base, there is a clear need to consider
quality of primary health services in both the public and private
sector in order to improve health outcomes. There is a tendency
for the private sector to provide better quality services, but further
research on the overall quality and testing feasibility and
effectiveness of mechanisms to improve quality will be critical
for future health gains in LMICs.
Research needs to standardise outcomes and measures of socio-
economic position across studies to improve comparability and to
assist in between-country dialogue on effective quality assurance
policies. Research on the effectiveness of market-led strategies to
influence the private sector is important. Studies of dual practice,
examining the same providers’ behaviour in the two settings, could
be useful specific studies in identifying factors in terms of the
setting. Lastly, establishing minimum standards of care, and
research to help identify effective approaches to achieve them, is
central to achieving the health gains that are possible with current
preventive and treatment medical technologies.
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Editors’ Summary
Background. The provision of private (‘‘for-profit’’ hospitals
and self-employed practitioners, and ‘‘not-for-profit’’ non-
government providers, including faith-based organizations)
versus public health care services in low and middle income
countries raises considerable ideological debate. Ideological
arguments aside—which can be very passionate on both
sides—there is general agreement that improving the quality
of both public and private health care could have a major
impact on improved health outcomes, especially as the
private sector is so widely used in low and middle income
countries. For example, almost three quarters and half of
children from the poorest households of South Asia and sub-
Saharan Africa, respectively, seek health care from a private
provider when they are ill. Private providers are also
increasingly responsible for outpatient care for non-
communicable diseases.
As a result of the mixed health care system in many low and
middle income countries, adequate oversight and steward-
ship of the mixed system from the national government is
essential yet often missing.
Why Was This Study Done? An understanding of how
quality and performance in the private sector compares with
that in the public sector would help governments to
prioritize where they need to concentrate their efforts. So,
for example, if the private sector is generally providing
poorer quality care than the public sector, then there is an
imperative to improve the quality and outcomes; on the
other hand, if the quality of care offered by the private sector
is good, the policy priority is to influence the market to
further improve access to such health care for low income
groups.
In order to help with this comparison, the researchers
wanted to systematically identify and summarize the results
of studies that directly compared the quality of care offered
by public providers with the one offered by ‘‘formal’’ private
providers (recognized by law) and ‘‘informal’’ private
providers (providers that are not legally recognized, such
as lay health workers and shop keepers). For the purposes of
this study the researchers focused their comparison on the
private and public provision of outpatient care in low and
middle income countries.
What Did the Researchers Do and Find? In their
literature review, the researchers searched for relevant
studies reported in English, French, or German and
published between January 1970 and April 2009. Only
studies that compared private and public outpatient
medical services in the same country, at the same time,
using the same methods, and which met particular quality
criteria, were included in the analysis. The researchers also
had strict criteria for including qualitative studies, and they
retrieved the full text of articles, contacted study authors
where appropriate, and verified with a second researcher
most (80%) of the extracted study data. In order to evaluate
and compare the studies, the researchers converted study
values to a linear 100% scale, calculated differences between
providers within studies, and summarized the median values
of the differences across studies.
The researchers identified a total of 8,812 relevant titles and
abstracts and found 80 studies that included direct
quantitative comparisons of public and private formal
providers. Ten studies included qualitative data. Most studies
were conducted after 1990, and mainly in sub-Saharan Africa
(n= 39) and Asia and the Pacific (n= 23). Most studies did not
report socio-economic status of public and private service
users, and only five studies presented data by different
income groups. No study compared the same individual
providers working in public and private care settings. Only
two studies compared public providers and private informal
providers, so the authors excluded these from subsequent
analysis.
For the formal sector, since the results for ‘‘for-profit’’ and
‘‘not-for-profit’’ providers were similar, the researchers
decided to combine the results. Overall, the researchers
found that the median values indicated that many services,
irrespective of whether public or private, scored low (less
than 50%) on infrastructure, clinical competence, and
practice. Generally, the private sector performed better in
relation to drug supply, responsiveness, and effort, but there
was no detectable difference between provider groups for
patient satisfaction. Furthermore, a synthesis of qualitative
data suggested that the private sector may be more client-
centered.
What Do These Findings Mean? Based on the findings of
this review, there is a clear need to consider the quality of
primary health services in both the public and private sector
in order to improve health outcomes in low and middle
income countries. These findings also indicate that, for some
aspects of care, on average the private sector provided
better quality services. The overall low quality of care in both
the formal private and public sector found in this review is
worrying, and calls for the governments of low and middle
income countries to find and implement effective strategies
to improve the quality in both sectors. This is particularly
important given the increasing volume of conditions that
require relatively sophisticated, long-term ambulatory
medical care, such as non-communicable diseases.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000433.
N This study is further discussed in a PLoS Medicine
Perspective by Jishnu Das
N WHO has more information on health service delivery in
low- and middle-income countries
N WHO has more information on noncommunicable diseases
N The World Bank’s World Development Report for 2004
addresses health care for poor people
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